Related Experiment Video

Updated: May 29, 2026

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System
10:51

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

Published on: April 23, 2021

Retraction Note: Mathematical modeling and statistical analysis of breast cancer drugs using M-polynomial indices for

Qasem M Tawhari1, Muhammad Naeem2, Saba Maqbool3

  • 1Department of Mathematics, College of Science, Jazan University, 45142, Jazan, Saudi Arabia.

Scientific Reports
|May 27, 2026
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Related Experiment Videos

Last Updated: May 29, 2026

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System
10:51

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

Published on: April 23, 2021

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

Articles linked to this work by shared authors, journal, and citation graph.

Enhanced induction of inflammatory cytokines in human lung cells infected with highly pathogenic recent H5N1/2024 avian influenza virus.

Archives of virology·2026

Operative Efficiency, Technical Workflow, and Perioperative Outcomes in Minimally Invasive Trans-Kambin Oblique Thoracic Interbody Fusion (MIS-OTIF): A Retrospective Clinical Analysis.

Cureus·2026

Linking innovation with hospital performance: the mediating role of experiential healthcare marketing.

Frontiers in health services·2026

Infection Rates Following Trans-Kambin Oblique Lateral-Posterior Lumbar Interbody Fusion and Associated Procedures: A Review of 2,069 Cases.

Cureus·2026

Dopant-driven photonic nonlinear optical responses in Mg4O3 electrides.

RSC advances·2026

Cerium-modified niobium oxide/reduced graphene oxide (Ce-Nb2O5/r-GO) hybrid: advances in charge transport dynamics for photocatalytic applications.

RSC advances·2026

Searching for separation between frequency-modulated calls of blue and fin whales.

Scientific reports·2026

Isolation and characterization of plant plasma membrane P-type H+-ATPase dimers.

Scientific reports·2026

Cold-induced vasomotion changes in healthy individuals and patients after median or ulnar nerve repair.

Scientific reports·2026

Integrated expression profiling reveals molecular crosstalk between CFTR, FASN, FRAP (mTOR), and BANK1 in hepatocellular carcinoma.

Scientific reports·2026

Low-cost IoT real-time environmental monitoring and one-hour LSTM forecasting for small-scale agricultural applications.

Scientific reports·2026

Emotion regulation strategy use and daily levels of affective arousal, affective valence and dissociation in a clinical sample.

Scientific reports·2026

Integrating network pharmacology and experimental validation to uncover the mechanisms of Ganoderma lucidum in ameliorating neuroinflammation in Alzheimer's disease.

The Journal of pharmacy and pharmacology·2026

Predictive Analysis on the Mechanism of Dendrobium officinale Polysaccharides in Treating Hepatic Fibrosis via Network Pharmacology and Molecular Docking.

BioMed research international·2026

Supramolecular strategy in traditional Chinese medicine processing: Mechanistic insights mediated by self-assembly.

Acta pharmaceutica Sinica. B·2026

Deciphering the interaction landscape of NDM-1 with a novel β-lactam-based inhibitor: implications for rational drug design.

In silico pharmacology·2026

Exploration of Bacopa monnieri-derived Green Ligands for Targeted IDH1 Inhibition in Glioblastoma.

Current drug discovery technologies·2026

Identification and 3D Modeling of Novel Drug Targets in Leishmania Major: An in-silico Approach.

Infectious disorders drug targets·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us